2-tert-butylhydroquinone has been researched along with Adenoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Guo, QL; Guo, XK; Hu, R; Jia, JM; Jiang, JW; Jiang, ZY; Sun, HP; Sun, ZY; Tao, L; Wang, YJ; Xi, MY; Xu, LL; Xu, XL; Xue, X; Yang, X; Ye, M; You, QD; Zhang, MY; Zhang, XJ; Zhu, JF | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Adenoma
| Article | Year |
|---|---|
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
Topics: Active Transport, Cell Nucleus; Adenoma; Animals; Antineoplastic Agents; Antioxidant Response Elements; Azoxymethane; Blotting, Western; Cell Nucleus; Colorectal Neoplasms; Dextran Sulfate; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Heme Oxygenase-1; Hep G2 Cells; Heterocyclic Compounds, 3-Ring; Humans; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred C57BL; Models, Chemical; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Neoplasms; NF-E2-Related Factor 2 | 2013 |